Please login to the form below
Sanofi and Ablynx sign €2.4bn nanobody deal
The duo will develop immune-mediated inflammatory disease candidates
Race to CGRP migraine drug finish line enters the final straight
US regulator keeps Aimovig ahead of competitors including Lilly’s galcanezumab
NICE backs Teva's Cinqaero for severe asthma
Ruling will allow it to compete with GSK's rival IL-5 inhibitor Nucala
Ashfield Healthcare launches Cirrus Communications
The new healthcare communications agency will have US and UK roots
IMI aims €130m at medical research's unanswered questions
Targets for the partnership’s latest funding round including Alzheimer’s
Vertex hits sweet spot with triple cystic fibrosis therapy
The new treatment could benefit up to 90% of patients with CF
Shake-up at GSK could claim antibiotics unit and UK facilities
The firm says its plans, which are expected to lead to 320 job cuts, are not related to Brexit
Cello Health acquires Advantage Healthcare to strengthen its US presence
Biopharmaceutical insight group boosts Cello’s reach
Biosimilars eat into J&J's Remicade sales
But its IL-23 inhibitor 'signals better times ahead'
Healthcare in the digital age
Prof Jan Kimpen on a decade of digital change in healthcare and its future direction of travel
-
Standing out in a crowdCelltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars
-
The Communiqué Awards at 20: Dennis O’BrienLucid's CEO on the Awards' enduring influence
-
Gilead gets OK for three-in-one hep C therapy in USFDA clears the new product for the most common HCV genotypes
-
Merck's new health charity strikes partnership deal with TanzaniaThe Merck Foundation will support oncology fellowship programmes for Tanzanian doctors
-
Spark closes on first US gene therapy approvalFDA starts review of Luxturna for patients with inherited retinal disease
-
Havas Group acquires SO What GlobalFounders Scott Clark and Oliver Parsons will continue to lead the SO team
-
Novo launches personalised diabetes management mobile app Partners with Glooko on app that syncs blood glucose and activity data
-
FDA rejects Amgen's osteoporosis hope romosozumabIts partner UCB plans to submit the medicine for European approval later this year
-
Amgen aspires to new Kyprolis label in the US and EuropeAppeals to regulators to add survival data to multiple myeloma drug's labelling
Latest appointments
-
NDA bolsters its senior teamHires Eva Lilienberg, Christine Chirdo and Barbara Clendenen
-
Nabriva Therapeutics appoints new chief commercial officer
Francesco Maria Lavino joins to support commercialisation of its new antibiotic
-
PharmaLex appoints Zabin Younes as associate director
She joins from ERA Consulting
-
Sophie Adlard joins J+D Consulting as a business analyst
She brings experience from Cancer Research UK, where she was a PhD student
-
Nova appoints Richard Limb as head of quality assuranceHe joins the privately-owned company from Pfizer
Featured jobs
- Group Account Director or Client Services Director – Healthcare ...
-
£80, 000 – £110, 000 benefits
- Senior Account Manager, highly regarded Medical Communications a...
-
Excellent Package
- (Senior) Account Manager - Medical Education
-
32 - 45, 000 D.O.E
-
*ACCOUNT MANAGER*
-
Competitive Salary Offered
-
*PROJECT MANAGER/ ACCOUNT MANAGER*
-
Competitive Salary Offered
-
*Middleweight Copywriter*
-
Competitive Salary
- Group Account Director, Healthcare Advertising/ Brand Comms, Lon...
-
Substantiel Package
-
Scientific Director
-
£70, 000 - £85, 000
- Senior Medical Writer, Medical Communications Agency
-
£40, 000 - £45, 000 benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Director of Rare Diseases, Healthcare Agency, London
-
Excellent Package
-
Principal Medical Writer
-
Great salary and benefits
Subscribe to our email news alerts
PMHub
Star
Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...
Latest intelligence
- Creativity in a complex landscape: a pharma perspective
- lue Latitude Health interviewed Mohamed Helal, Marketing Lead for Immunology IBVT at EMEA level for Janssen, to find out his view what an exceptional creative campaign looks like when working...
- Keeping it real
- Virtual and augmented realities are helping to shape the future possibilities for healthcare...
- Perfecting the pharmaceutical pipeline with AI
- How AI can transform the way we identify and validate research...
Quick links
Infographics
